NEPWA
ABBV icon

New England Private Wealth Advisors’s AbbVie ABBV Stock Holding History

New England Private Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,744
Closed -$584K – 80
2019
Q3 		$584K Buy
7,744
+30
+0.4% +$2.06K 0.14% 86
2019
Q2 		$563K Buy
7,714
+26
+0.3% +$2.04K 0.14% 85
2019
Q1 		$620K Buy
7,688
+19
+0.2% +$1.55K 0.16% 81
2018
Q4 		$703K Buy
7,669
+663
+9% +$58.3K 0.21% 71
2018
Q3 		$662K Sell
7,006
-430
-6% -$40.8K 0.18% 77
2018
Q2 		$695K Sell
7,436
-498
-6% -$48.6K 0.2% 71
2018
Q1 		$750K Buy
7,934
+368
+5% +$40.4K 0.21% 68
2017
Q4 		$733K Sell
7,566
-877
-10% -$82.7K 0.21% 67
2017
Q3 		$752K Buy
8,443
+10
+0.1% +$761 0.22% 62
2017
Q2 		$613K Buy
8,433
+10
+0.1% +$672 0.19% 73
2017
Q1 		$548K Buy
8,423
+212
+3% +$13.3K 0.18% 74
2016
Q4 		$516K Sell
8,211
-869
-10% -$53K 0.18% 70
2016
Q3 		$575K Buy
9,080
+10
+0.1% +$647 0.21% 67
2016
Q2 		$562K Buy
9,070
+208
+2% +$12.7K 0.21% 64
2016
Q1 		$505K Buy
8,862
+509
+6% +$28.4K 0.21% 68
2015
Q4 		$493K Buy
8,353
+206
+3% +$11.9K 0.2% 68
2015
Q3 		$444K Buy
8,147
+6
+0.1% +$391 0.19% 65
2015
Q2 		$547K Buy
+8,141
New +$531K 0.21% 60
2015
Q1 		– Sell
-9,524
Closed -$627K – 106
2014
Q4 		$627K Buy
9,524
+2
+0% +$126 0.25% 58
2014
Q3 		$550K Buy
9,522
+104
+1% +$5.77K 0.22% 62
2014
Q2 		$532K Buy
+9,418
New +$494K 0.22% 60

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

New England Private Wealth Advisors's ABBV Position: Q4 2019 in Review

New England Private Wealth Advisors sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 7,744 shares — an estimated $584K sold.

New England Private Wealth Advisors first reported a position in ABBV in Q2 2014 and held it in 21 quarters. The position peaked at $752K in Q3 2017. 2,244 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • New England Private Wealth Advisors reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • New England Private Wealth Advisors sold 7,744 AbbVie shares in Q4 2019, an estimated $584K.
  • New England Private Wealth Advisors first reported a position in AbbVie in Q2 2014 and held it in 21 quarters.
  • New England Private Wealth Advisors's AbbVie position peaked at $752K in Q3 2017.
  • 2,244 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on New England Private Wealth Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.